# A Study to Understand How a Study Medicine Called PF-07328948 is Absorbed and Processed in the Body of Healthy Male Adults

> **NCT07508228** · PHASE1 · RECRUITING · sponsor: **Pfizer** · enrollment: 8 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Oral [14C]PF-07328948
- **DRUG:** Oral Unlabeled PF-07328948
- **DRUG:** IV [14C]PF-07328948

## Key facts

- **NCT ID:** NCT07508228
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-03
- **Primary completion:** 2026-09-24
- **Final completion:** 2026-09-24
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07508228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07508228, "A Study to Understand How a Study Medicine Called PF-07328948 is Absorbed and Processed in the Body of Healthy Male Adults". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07508228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*